Exosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented by Product (Kits and Reagents, Instruments, and Other Products), By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), By Region and Com
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationExosome Research Market - Global Industry Size, Share, Trends, Opportunities, and Forecast, 2018-2028, Segmented by Product (Kits and Reagents, Instruments, and Other Products), By Indication (Cancer, Neurodegenerative diseases, Cardiovascular diseases, Infectious diseases, and Others), By Application (Biomarkers, Vaccine Development, Tissue Regeneration, and Other Applications), By Region and Com
According to the GLOBOCAN 2020 report, 19.29 million people are living with cancer, and this number is expected to rise over the next two decades across the world. With the rising number of cancer cases, it is believed that the application of exosomes in coping with cancer would be high, which is expected to contribute to market growth.
Increase in Research Funding
The increase in research funding has been a significant driver of growth in the global exosome research market. This funding has enabled researchers to conduct more extensive and in-depth studies on exosomes, leading to a greater understanding of their biology and potential clinical applications. Increased funding for exosome research has allowed for the development of new technologies and methodologies for the isolation, analysis, and characterization of exosomes. This has led to the creation of new products and services in the exosome research market and new diagnostic and therapeutic applications for exosomes. With greater funding comes the ability to expand the scope of research into exosomes. This has allowed researchers to explore new areas of exosome biology and investigate their potential roles in a wider range of diseases and conditions. This expanded research scope has led to a greater understanding of the clinical applications of exosomes and has driven growth in the exosome research market.
Increased research funding has made exosome research a more attractive area for investment, leading to the creation of new companies and products in the exosome research market. This investment has helped to drive innovation and accelerate the development of exosome-based therapies and diagnostics. Several companies have recently expanded their pipelines to include exosome-based therapies. For example, Codiak Biosciences has entered into a collaboration with Jazz Pharmaceuticals to develop exosome-based therapies for the treatment of cancer. The development of new and improved exosome isolation technologies has been a key area of focus in the exosome research market. Recent advancements in this area include the use of microfluidic devices for high-throughput exosome isolation and the development of new methods for the isolation of exosomes from specific cell types.
Advances in Exosome Isolation and Analysis Technologies
Advances in exosome isolation and analysis technologies have had a significant impact on the global exosome research market. These advances have made it easier and more efficient for researchers to study exosomes, leading to a better understanding of their biology and potential clinical applications. Advances in exosome isolation and analysis technologies have led to improvements in accuracy and efficiency, allowing researchers to obtain high-quality exosome samples and analyze them more quickly and accurately. This has helped to accelerate research and development in the exosome research market. New technologies have been developed that allow the detection and analysis of smaller amounts of exosomes, increasing the sensitivity of exosome-based assays and leading to more precise results. This has opened up new avenues of research and led to the development of new products and services in the exosome research market.
Advances in exosome isolation and analysis technologies have led to the development of new products and services in the exosome research market, including kits for exosome isolation and analysis, exosome-based diagnostics, and exosome-based therapeutics. These products and services have driven growth in the exosome research market and created new opportunities for companies operating in this space. The improved accuracy and sensitivity of exosome isolation and analysis technologies have led to a better understanding of exosome biology and its role in various diseases and conditions. This increased understanding has driven the development of new diagnostic and therapeutic applications for exosomes, which has further contributed to the growth of the exosome research market.
Growing Awareness of Potential Clinical Applications of Exosomes
The growing awareness of the potential clinical applications of exosomes has had a significant impact on the global exosome research market. As researchers and clinicians have become more aware of the unique properties and functions of exosomes, interest in their potential therapeutic and diagnostic applications has grown. As awareness of the potential clinical applications of exosomes has grown, investment in the development of exosome-based therapeutics and diagnostics has increased. This has led to the creation of new companies and products in the exosome research market, driving growth and innovation. The potential clinical applications of exosomes include the treatment of a wide range of diseases and conditions, including cancer, neurological disorders, and cardiovascular diseases.
As awareness of this potential has grown, researchers have focused on developing exosome-based therapies, leading to the creation of new products and services in the exosome research market. Exosomes have also shown promise as biomarkers for the diagnosis of various diseases and conditions. Growing awareness about this potential has led to the development of new exosome-based diagnostic tests, which have driven the exosome research market. As exosome-based therapies and diagnostics have moved closer to clinical use, regulatory agencies have become increasingly involved in the development and approval process. Growing awareness of the potential clinical applications of exosomes has led to increased regulatory scrutiny, which has helped to ensure the safety and efficacy of exosome-based products and services.
Increasing Prevalence of Chronic Diseases
The increasing prevalence of chronic diseases is impacting the global exosome research market substantially. Chronic diseases, such as cancer, cardiovascular disease, and neurological disorders, are major public health challenges, affecting millions of people worldwide. Exosomes have shown promise as potential diagnostic and therapeutic tools for these and other chronic diseases, driving growth in the exosome research market.
The rise in chronic diseases has led to a growing focus on research, creating an opportunity for the potential role of exosomes in disease diagnosis, treatment, and monitoring. Researchers' search for exosomes' potential as biomarkers and therapeutics is aiding the market’s growth. Exosomes have shown promise as a novel class of therapeutics, capable of delivering drugs and genetic material to specific cells and tissues.
The demand for new treatments has also been on the rise due to the rising prevalence of chronic diseases, driving the development of exosome-based therapies and products.
Exosomes have also shown promise as diagnostic tools for various chronic diseases. By analyzing exosomes present in bodily fluids, researchers can identify biomarkers that may indicate the presence of disease. This has driven the development of new exosome-based diagnostic tests and tools, leading to an expansion in the exosome research market. The increasing prevalence of chronic diseases has created a significant market demand for new and effective therapies and diagnostic tools. As exosomes have shown promise as a potential solution to these challenges, the exosome research market has grown in response to this demand.
Recent Developments
EV Shuttleâ„¢ Exosome Isolation Kit (System Biosciences LLC, 2021)
ExoLutionâ„¢ Plus (BioVision Inc., 2020)
ExoTestâ„¢ Prostate (NanoView Biosciences Inc., 2019)
EV-TRACK (The International Society for Extracellular Vesicles, 2019)
ExoCarta (Johns Hopkins University, 2018)
Download Free Sample Report
Market Segmentation
The global exosome research market can be segmented by product, indication, application, and region. Based on the product, the market can be segmented into kits and reagents, instruments, and other products. Based on indication, the market can be differentiated into cancer, neurodegenerative diseases, cardiovascular diseases, infectious diseases, and others. Based on application, the market can be grouped into biomarkers, vaccine development, tissue regeneration, and other applications.
Market Players
Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, and NX PharmaGen are some of the leading players operating in the global exosome research market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Product By Indication By Application By Region |
| Regional Scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key Companies Profiled | Thermo Fisher Scientific., System Biosciences., Bio-Techne., Lonza., QIAGEN., ExoDx., Hitachi Chemical., Aethlon Medical., NanoSomiX., Malvern Panalytical., Sistemic Scotland Limited, NX PharmaGen |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy